Biology of breast cancer in Nigerian women: A pilot study

Annals of African Medicine

Volumn 11, Issue 3, 2012, Pages 169-175

  Adisa, C A ^a   Eleweke, N ^a   Alfred Au, A ^b   Campbell, M J ^c   Sharma, R ^c   Nseyo, O ^c   Tandon, V ^c   Mukhtar, R ^c   Greninger, A ^c   Risi, J ^c   Esserman, L J ^c  

^a ABIA STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; tumor associated macrophages; tumor microenvironment

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RNA;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NIGERIA; ONSET AGE; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; RACE DIFFERENCE; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; WOMEN'S HEALTH;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; BIOPSY; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; NIGERIA; PHENOTYPE; PILOT PROJECTS; PREVALENCE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84862258491     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.96880     Document Type: Article

References (42)

1. Parkin DM, Fernandez LMG. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12:S70-80. (Pubitemid 43385274)
2. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-28. (Pubitemid 38263181)
3. Ries L, Eisner M, Kosary C, Hankey BF, Miller BA, Clegg L, et al. SEER cancer statistics review, 1975-2002. Vol. 2006: NCI; 2005.
4. Newman LA. Breast cancer in African-American women. Oncologist 2005;10:1-14. (Pubitemid 40171247)
5. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705-12. (Pubitemid 24138977)
6. World Health Organization. The World Health Report 2006dworking together for health. Available at: http://www.who.int/whr/2006/en/index.html. [Accessed 2006 April 11].
7. Solanke TF, Adebamowo CA. Report of the state of the art in Oncology in Ibadan and Ife National Headquarters of Cancer Registries in Nigeria. UCH Ibadan; 1996.
8. Adebamowo CA, Adekunle OO. Case controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 1999;86:665-8. (Pubitemid 29248362)
9. Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg 1992;79:771-5.
10. Atoyebi OA, Atimomo CE, Adesanya AA, Beredugo BK, da Rocha-Afodu JT. An appraisal of 100 patients with breast cancer seen at the Lagos University Teaching hospital, Lagos, Nigeria. Niger Q J Hosp Med 1997;7:104-8.
11. Anyanwu SN. Breast cancer in Eastern Nigeria: A ten year review. West Afr J Med 2000;19:120-5.
12. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 2002;99:15687-92. (Pubitemid 35403992)
13. Wang D, Urisman A, Liu YT, Springer M, Ksiazek TG, Erdman DD, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003;1:E2.
14. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat 2011;128:703-11.
15. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, et al. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat 2011;130:635-44.
16. Hayanga AJ, Newman LA. Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: The need for more genetic epidemiology. Chest Surg Clin N Am 2007;87:551-68. (Pubitemid 46693949)
17. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population differences in breast cancer: Survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009;27:4515-21.
18. Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women? Cancer 2005;103:1540-50. (Pubitemid 40490014)
19. Reis LA, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK, editors. SEER cancer statistics review, 1973-1996. NIH Pub. No, 99-2789. Bethesda: National Cancer Institute; 1999.
20. Joslyn SA. Hormone receptors in breast cancer: Racial differences in distribution and survival. Breast Cancer Res Treat 2002;73:45-59. (Pubitemid 34548165)
21. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-502. (Pubitemid 43854964)
22. Miller BA, Hankey BF, Thomas TL. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 2002;155:534-45. (Pubitemid 34208045)
23. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD.
24. Eniu A, Carlson RW, Aziz Z, Bines J, Hortobágyi GN, Bese NS, et al. Breast cancer in limitedresource countries: Treatment and allocation of resources. Breast J 2006;12:S38-53. (Pubitemid 43385272)
25. Mbonde MP, Amir H, Akslen LA, Kitinya JN. Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population. East Afr Med J 2001;78:360-5. (Pubitemid 33597135)
26. Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease? Ann Surg Oncol 2008;15:1983-8.
27. Yarney J, Vanderpuye V, Clegg Lamptey JN. Hormone receptor and HER-2 expression in breast cancers among Sub-Saharan African women. Breast J 2008;14:510-1.
28. Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer 2009;125:1663-70.
29. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: A study of 798 tumors. Breast 2000;9:267-70.
30. Lokuhetty MD, Ranaweera GG, Wijeratne MD, Wickramasinghe KH, Sheriffdeen AH. Profile of breast cancer in a group of women in a developing country in South Asia: Is there a difference? World J Surg 2009;33:455-9.
31. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 2002;99:15687-92. (Pubitemid 35403992)
32. Wang D, Urisman A, Liu YT, Springer M, Ksiazek TG, Erdman DD, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003;1:E2.
33. Sgambato A, Cittadini A. Inflammation and cancer: A multifaceted link. Eur Rev Med Pharmacol Sci 2010;14:263-8.
34. Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009;214:761-77.
35. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009;30:1073-81.
36. Sica A, Allavena P, Mantovani A. Cancer related inflammation: The macrophage connection. Cancer Lett 2008;267:204-15.
37. Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2009;124:263-6. (Pubitemid 43121975)
38. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: Correlations with prognostic parameters. J Exp Clin Cancer Res 2006;25:365-72. (Pubitemid 44763728)
39. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-83. (Pubitemid 40827339)
40. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000;6:3282-9. (Pubitemid 30637758)
41. Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 2008;8:243-52. (Pubitemid 351881350)
42. Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, et al. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol 2010;161:471-9.